ライフサイエンスコーパス: muscle strength

1 y nutrition supplementation on adult LBM and muscle strength.

2 ad a positive association with adult LBM and muscle strength.

3 other skeletal muscle diseases with loss of muscle strength.

4 (daily TV viewing time and internet use) and muscle strength.

5 stretching and resistance exercises improved muscle strength.

6 m (SR), but came at the expense of decreased muscle strength.

7 and improved pole balance, but no change in muscle strength.

8 cular atrophy associated with a reduction in muscle strength.

9 ber and severity of lymphedema symptoms, and muscle strength.

10 ype IIb fiber hypertrophy, and ultimately in muscle strength.

11 rated below normative values for VO2peak and muscle strength.

12 agnetic resonance imaging, and knee extensor muscle strength.

13 ment in muscle strength or maintained normal muscle strength.

14 es lean body mass, bone mineral content, and muscle strength.

15 ol subjects between genotype and inspiratory muscle strength.

16 ished test that is used to assess expiratory muscle strength.

17 entary test for the assessment of expiratory muscle strength.

18 estation may have long-term effects on adult muscle strength.

19 standard measures of functional capacity and muscle strength.

20 ted men failed to demonstrate improvement in muscle strength.

21 complexity and function resulting in reduced muscle strength.

22 zyme function, which are likely to influence muscle strength.

23 milarly hinders regeneration and compromises muscle strength.

24 o effect on serum creatine kinase levels and muscle strength.

25 core for the ICU scores with improvements in muscle strength.

26 nerve conduction velocities and ameliorated muscle strength.

27 rength, and diaphragm function and increased muscle strength.

28 arked by decreased lifespan, body weight and muscle strength.

29 lure, with specific attention to respiratory muscle strength.

30 of the adequacy of recovery of postoperative muscle strength.

31 th the ALSFRS-R (0.43 (0.39-0.46), p<0.001), muscle strength (0.55 (0.51-0.58), p<0.001) and overall

32 ygen consumption per unit time [$$ VO2], and muscle strength (1-repetition maximum strength).

33 ry and exercise compliance, and assessed for muscle strength (1-repetition maximum technique), cardio

34 Only stretching and resistance improved muscle strength (16% increase; P<.001).

35 eg LTM (0.22 kg; 95% CI: 0.02, 0.42 kg), and muscle strength (18%; 95% CI: 0.03, 0.34) than did the C

36 h (64%), provide more energy (31%), increase muscle strength (25%), and enhance performance (17%).

37 ngth (2.3 kg; 95% CI: 0.8, 3.7 kg), and 1-RM muscle strength (4.0%; 95% CI: 0.8%, 7.3%) (all P < 0.05

38 study of 6- and 12-month physical outcomes (muscle strength, 6-minute-walk distance, and Short Form

39 om were detected a median of 2.4 days and in muscle strength a median of 4.8 days after HBAT.

40 effects of median nerve stimulation on pinch muscle strength (a function mediated predominantly by me

41 d on manual and quantitative measurements of muscle strength, a disease-modifying effect of creatine

42 ts in physical abilities, including balance, muscle strength, ability to transfer from one position t

43 y adaptations in genes associated with diet, muscle strength, agility, and other traits responsible f

44 X) in ACTN3 results in significantly reduced muscle strength and a longer 10 m walk test time in youn

45 pproximately 25% of animals, but with normal muscle strength and a normal lifespan.

46 ed that concentric/isometric strain improved muscle strength and alleviated muscular dystrophy by lim

47 d with significant impressive improvement in muscle strength and amelioration of fibrosis.

48 esults also show the importance of improving muscle strength and area and lowering muscle adipose tis

49 uce a reproducible increase in both skeletal muscle strength and cardiac contractile performance that

50 survivors that is characterized by impaired muscle strength and causes functional disability.

51 trate that Dox treatment of P30 mice reduced muscle strength and compound muscle action potentials.

52 Myosin is the primary regulator of muscle strength and contractility.

53 o poor linear growth, there is a decrease in muscle strength and coordination, impaired cerebral func

54 igated whether a linear relationship between muscle strength and cross-sectional area (CSA) is preser

55 ylline demonstrated improved AROM, PROM, and muscle strength and decreased limb edema and pain.

56 ement, and the relationship with measures of muscle strength and disability was conducted.

57 cise performance, respiratory and quadriceps muscle strength and endurance and quality-of-life and dy

58 uation of cachexia with preserved whole body muscle strength and endurance capacity in the absence of

59 l and eugonadal patients had equivalent limb muscle strength and endurance.

60 nown about the effect of statins on skeletal muscle strength and exercise performance.

61 fficient data to determine if statins affect muscle strength and exercise performance.

62 Muscle strength and function correlated directly with se

63 Muscle strength and function improved over time without

64 he clinical history, laboratory findings and muscle strength and function in 57 patients with genetic

65 the past year and includes methods to assess muscle strength and function in children with myositis.

66 eter, resulting in long-term improvements in muscle strength and function in mdx mice.

67 These data suggest that differences in whole muscle strength and function that are often observed wit

68 condary outcome measures of creatine kinase, muscle strength and function, motor nerve conduction, ac

69 improve function through a direct effect on muscle strength and function.

70 ultifidus: timed up and go) as well as trunk muscle strength and functional ability (trunk composite

71 Muscle strength and functional capacity were assessed be

72 rength training on the neuromuscular system (muscle strength and functional capacity) of older women.

73 pplementation caused greater improvements in muscle strength and functional capacity.

74 Muscle strength and functional mobility were also measur

75 Secondary endpoints were urinary continence, muscle strength and functional status, the need for cort

76 Older men and women with weak muscle strength and high BMI have considerably poorer pe

77 evere motor abnormalities, major deficits in muscle strength and histopathological changes in muscle.

78 rgement of NMJs and substantial increases in muscle strength and life span.

79 of ER stress, significantly reduced skeletal muscle strength and mass in both control and LLC-bearing

80 and exogenous trophic factors on extraocular muscle strength and mass were examined in the developing

81 analysis was used to examine trajectories of muscle strength and mobility across time by sex as condi

82 ion of metabolic genes and induced a loss of muscle strength and morphological deterioration of the m

83 dictive for the patient's functional status, muscle strength and mortality risk.

84 recovery after cerebral ischemia, as well as muscle strength and motor function.

85 x studies examining the effect of statins on muscle strength and nine studies examining their effect

86 Age-related sarcopenia describes the loss of muscle strength and often accompanies an increase in adi

87 Resistance training (RT) improves muscle strength and overall physical function in older a

88 ssessing: physiological determinants of peak muscle strength and oxidative capacity and muscle biopsy

89 dy composition (including reducing IMAT) and muscle strength and physical function in obese elderly,

90 Deficits in quadriceps muscle strength and physical performance are common in L

91 ietary intakes of antioxidants with skeletal muscle strength and physical performance in elderly pers

92 Muscle strength and physical performance in old age migh

93 ndividuals who have had recent falls and low muscle strength and power.

94 This leads to increase in muscle strength and prevents cardiac pump failure induce

95 with impaired versus nonimpaired measures of muscle strength and pulmonary function had significantly

96 Targeted deletion of TRAF6 improves muscle strength and reduces fiber necrosis, infiltration

97 for enhancing the effects of PRT on LTM and muscle strength and reducing circulating IL-6 concentrat

98 n situ protocols in the mdx mouse to measure muscle strength and resistance to eccentric contraction-

99 These data suggest that increases in muscle strength and size were not influenced by the pred

100 week (every third day) that maintained whole muscle strength and size.

101 nal associations between functional decline, muscle strength and survival with plasma creatinine were

102 In addition, both muscle strength and the amplitude of MEPCs were lower in

103 is reflected in loss of range of motion and muscle strength and the development of limb edema and pa

104 re the time to achieve >/=20% improvement in muscle strength and the proportions of patients in the e

105 -year rates of decline in both knee extensor muscle strength and walking speed in 641 women with hype

106 ciation of sarcopenic obesity and changes in muscle strength and weight with the risk of mortality.Pa

107 in 1 second was also associated with weaker muscle strength and with a greater risk of self-reported

108 with glucose dysregulation, lower levels of muscle strength, and a heightened risk of disability.

109 Magnetic resonance imaging (MRI), muscle strength, and blood parameters were used as outco

110 esting included assessment of CRF (VO2peak), muscle strength, and body composition (%fat).

111 ent mice prevents muscle pathology, improves muscle strength, and dramatically increases life expecta

112 Therefore, exercise can improve gait speed, muscle strength, and fitness for patients with Parkinson

113 se ALS, the drug delayed loss of neurons and muscle strength, and increased mouse survival.

114 ciated with glucose dysregulation, decreased muscle strength, and increased risk of disability.

115 unction, body composition, aerobic capacity, muscle strength, and inflammatory/antiinflammatory bioma

116 e promote gains in body weight, muscle mass, muscle strength, and lean body mass in HIV-infected men

117 with objective measures of aerobic fitness, muscle strength, and muscle endurance, using data on 31-

118 ation of their joint structure and function, muscle strength, and neuromuscular function, and people

119 esting energy expenditure, cardiac function, muscle strength, and number of reconstructive procedures

120 y involves complex effects on balance, gait, muscle strength, and other features of motor coordinatio

121 x recipients have significantly reduced CRF, muscle strength, and physical activity.

122 included demographic information, quadriceps muscle strength, and QA using a burst-superimposition is

123 ized APA and its impact on aerobic capacity, muscle strength, and quality of life before LT.

124 availability, safety, bone turnover markers, muscle strength, and quality of life.

125 ody composition, resting energy expenditure, muscle strength, and serum human growth hormone, insulin

126 stay, physical function and quality of life, muscle strength, and ventilator-free days were included.

127 ung function, exercise capacity, respiratory muscle strength, and ventilatory efficiency.

128 pervised or home-based) on body composition, muscle strength, and walking capacity of liver transplan

129 ents, exercise is able to improve lean mass, muscle strength, and, as a consequence, aerobic capacity

130 ke (peak Vo2); isokinetic muscle testing for muscle strength; and dual-energy X-ray absorptiometry sc

131 ons of extremity, hand grip, and respiratory muscle strength; anthropometrics (height, weight, mid-ar

132 y 35% of children had diminished respiratory muscle strength (aPiMax </= 30 cm H2O) at the time of ex

133 ia is defined, both low muscle mass and poor muscle strength are clearly highly prevalent and importa

134 Strikingly, we show that changes in muscle strength are proportional to dystrophin expressio

135 lower limbs (medical research council graded muscle strength as 4+ out of 5) that was associated with

136 arterial blood gases (ABGs), and respiratory muscle strength as estimated by maximum static inspirato

137 (-0.30 kg/kg) from baseline in weight-scaled muscle strength as indicated by QMA, and the dutasteride

138 d histological muscle pathology and improved muscle strength as well as exercise performance.

139 orrelates with reduced fibrosis and improved muscle strength as well as reduced natural killer T (NKT

140 atment resulted in a significant increase in muscle strength, as determined by generation of specific

141 Each respiratory muscle strength assessment individually achieved statist

142 e, setting and method, and equipment of limb muscle strength assessment) and reliability scores were

143 ere obtained on reliability of nonvolitional muscle strength assessment.

144 ower of invasive and noninvasive respiratory muscle strength assessments for survival or ventilator-f

145 The combination of skin and muscle strength assessments makes this easily administer

146 ncreases in IMAT may contribute to losses in muscle strength associated with reduced physical activit

147 Two patients maintained their increased muscle strength at 52 weeks, and 1 of these patients mai

148 ilitary conscripts, low aerobic capacity and muscle strength at age 18 years were associated with inc

149 ured creatine kinase, exercise capacity, and muscle strength before and after atorvastatin 80 mg or p

150 ockout mouse model, which also shows reduced muscle strength, but is protected from stretch-induced e

151 als is independently associated with greater muscle strength, but not with the mobility score, in old

152 ctivator, CK-2017357, as a means to increase muscle strength by amplifying the response of muscle whe

153 come measures included hindlimb and forelimb muscle strength by Grip Strength Meter and quantitative

154 ral magnesium supplementation on respiratory muscle strength by using manuvacuometry and the Shwachma

155 , well tolerated, and effective at improving muscle strength, cardiovascular endurance and functional

156 ved lean body mass, bone mineral content and muscle strength compared with controls during treatment,

157 stantial improvements on behavioral tests of muscle strength, coordination, and locomotion, indicatin

158 The improvement in muscle strength correlated with stimulus intensity and w

159 Muscle strength/CSA relationships were significantly low

160 ht, body mass index (BMI), body composition, muscle strength, cytokines, complications, and QL.

161 sical performance deteriorated over 3 y with muscle strength declining more than the mobility score i

162 ant bulbar involvement, tests of respiratory muscle strength do not predict hypercapnia.

163 Thigh muscle strength does not appear to predict incident radi

164 The progressive loss of muscle strength during aging is a common degenerative ev

165 More importantly, reduced muscle strength during critical illness is an independen

166 s, and disability often coexist, but whether muscle strength during midlife predicts old age function

167 ticity at the neuromuscular junction and for muscle strength, endurance, and motor coordination in mi

168 Muscle strength fell by 3.0 kg in 3 years in both contin

169 r treatment led to more than 97% recovery in muscle strength for both the specific twitch force and t

170 est protein supplements primarily to promote muscle strength, function, and possibly size.

171 Poor muscle strength, functional limitations, and disability

172 confidence interval 0.13, 0.78), peripheral muscle strength (g = 0.27, 95% confidence interval 0.02,

173 idence interval 0.02, 0.52), and respiratory muscle strength (g = 0.51, 95% confidence interval 0.12,

174 sures were standardized measures of skeletal muscle strength, gait, balance, quality of life, and bod

175 the following 2 functional composite scores: muscle strength (handgrip, arm, and leg) and mobility (t

176 Reduced respiratory muscle strength has been reported in chronic heart failu

177 f joint or muscle innervation, or inadequate muscle strength have increased risk of joint damage duri

178 nificantly correlated with age, percent fat, muscle strength, hematocrit, and self-reported physical

179 eg resistance training led to: (i) increased muscle strength; (ii) myofibre damage and regeneration;

180 cts on atorvastatin or placebo had decreased muscle strength in 5 of 14 and 4 of 14 variables, respec

181 utrition with adult lean body mass (LBM) and muscle strength in a birth cohort that was established t

182 usefully be included in tests of respiratory muscle strength in ALS and will be helpful in assessing

183 (ATA 842) for 4 wk increased muscle mass and muscle strength in both groups.

184 in the VDR gene are associated with skeletal muscle strength in both patients and control subjects, w

185 ibitor treatment may halt or slow decline in muscle strength in elderly women with hypertension and w

186 Strength training increased muscle strength in elderly women.

187 asing AMPD1 expression resulted in decreased muscle strength in healthy mice.

188 s on MRI, which correlated well with reduced muscle strength in hip and knee flexors and extensors.

189 Provocation reduced muscle strength in HyperPP (before provocation, median M

190 d significant increases in maximum voluntary muscle strength in leg press (range, 22%-30%), leg curls

191 eight, muscle mass, muscle size and absolute muscle strength in mdx mouse muscle along with a signifi

192 t birth weight has an important influence on muscle strength in midlife independent of later body siz

193 Good muscle strength in midlife may protect people from old a

194 signaling increases muscle mass and improves muscle strength in mouse models of primary muscle diseas

195 might be a therapeutic mechanism to increase muscle strength in nebulin deficient muscle.

196 gestive evidence that these drugs may reduce muscle strength in older patients and alter energy metab

197 ent reduction in physical performance and in muscle strength in older women who do not have CHF.

198 escribes strategies to control perioperative muscle strength in patients undergoing ambulatory surger

199 ed improve both the SK score and respiratory muscle strength in pediatric patients with CF.

200 nificant morbidity associated with decreased muscle strength in the older kidney transplant populatio

201 interventions to reduce fat mass and improve muscle strength in the prevention of future functional l

202 uction in endurance and 1.6-fold decrease in muscle strength in these mice.

203 Reliable monitoring of muscle strength in this environment is difficult.

204 inimum Feret diameter, p < 0.001), increased muscle strength in vitro (p < 0.001) and in vivo (p = 0.

205 ovide a more biological method of decreasing muscle strength in vivo than exogenously administered to

206 eased muscle action potential amplitudes and muscle strengths in the range of wild-type mice.

207 From week 2 (baseline) to week RT12, muscle strength increased in muscle groups trained in th

208 s exhibited major clinical improvement, with muscle strength increasing over baseline by 36-113%.

209 hysical function, peripheral and respiratory muscle strength, increasing ventilator-free days, and de

210 rect correlation of testosterone levels with muscle strength indicates that androgens may have a posi

211 xins, a more biological approach to decrease muscle strength is possible and demonstrate the potentia

212 d from loss of white adipose tissue, reduced muscle strength, kyphosis, alopecia, hypothermia and sho

213 y improve preoperative functional status and muscle strength levels in persons undergoing THA.

214 iated with frailty such as falls and reduced muscle strength likely contribute to fractures, causing

215 and passive range of motion (AROM and PROM), muscle strength, limb edema, and pain.

216 ts and to assess whether this change affects muscle strength loss.

217 ng balance (Functional Reach Test), skeletal muscle strength (manual muscle testing with dynamometry)

218 Drug efficacy was tested by measuring muscle strength manually (34 muscle groups) and quantita

219 Sex steroid + GH increased muscle strength marginally and VO( 2)max in men, but wom

220 , fatigue, erectile dysfunction, and reduced muscle strength/mass.

221 ltifactorial, changes in DCO and respiratory muscle strength may contribute to its intensity.

222 To establish a functional in vitro assay for muscle strength, mdx murine myoblasts, the genetic homol

223 Aerobic capacity and muscle strength (measured in watts and newtons per kilog

224 The principal efficacy outcome was muscle strength, measured by quantitative dynomometry.

225 Voluntary muscle strength measurement has proven reliable in criti

226 A study was included if reliability of muscle strength measurements was determined in this popu

227 om a previously published report respiratory muscle strength measurements were available for 78 patie

228 muscle weakness using the DAS and ratings of muscle strength obtained independently from therapists a

229 Maximal improvements in muscle strength occurred as early as 12 weeks after the

230 tinuously had a lower mean 3-year decline in muscle strength of -1.0 kg (SE 1.1) compared with -3.7 (

231 Quantitative muscle strength of knee extensor and the IBM functional

232 On the day of extubation, muscle strength of the four limbs, criteria for delirium

233 Improvement was seen in muscle strength of the lower (191 +/- 75 to 265 +/- 67 p

234 o significant changes in several measures of muscle strength or exercise capacity with atorvastatin,

235 tatin for 6 months does not decrease average muscle strength or exercise performance in healthy, prev

236 rovements noted in exploratory end points of muscle strength or function, but the study was not power

237 urvival time without demonstrated effects on muscle strength or function, is the only approved treatm

238 ndurance-type exercise but has no effects on muscle strength or hypertrophy.

239 and 10 patients had either an improvement in muscle strength or maintained normal muscle strength.

240 ant effect of BK(2)R genotype on inspiratory muscle strength or on any variable in control subjects w

241 al working groups have proposed that loss of muscle strength or physical function should also be incl

242 e peak volume of oxygen consumed per minute, muscle strength, or insulin sensitivity.

243 physical activity level (P < 0.01), and less muscle strength (P < 0.001); these differences between g

244 nce intervals -13.943 to -3.015) decrease in muscle strength (P < 0.006).

245 OnTrack also resulted in better outcomes for muscle strength (P = .002) and physical fatigue (P < .00

246 16), percent age-predicted Vo2 (P=0.03), and muscle strength (P=0.05), and a trend toward higher self

247 Exercise participation increased muscle strength preoperatively (18% in THA patients and

248 l disorders, may reflect disordered balance, muscle strength, proprioception, and/or patterned gait.

249 cardiorespiratory fitness (CRF, VO(2peak)), muscle strength (quadriceps peak torque), body compositi

250 ion reduces age-related deficits in skeletal muscle strength, quality, and mass, similar to ursolic a

251 ntly reduce age-related deficits in skeletal muscle strength, quality, and mass: ursolic acid (a pent

252 ne showed reduced survival, body weight, and muscle strength, relative to untreated animals.

253 ram intervals, cardiac ejection fraction and muscle strength remained normal.

254 he enhanced muscle Ca(2+), force and in vivo muscle strength responses following isoproterenol stimul

255 lerosis (ALS) and measurement of respiratory muscle strength (RMS) has been shown to have prognostic

256 and lower extremities measured by a 5-point muscle strength score and a 7-point Functional Independe

257 total quantity, was associated with a higher muscle-strength score in both sexes throughout follow-up

258 rogate marker for the characteristic loss of muscle strength seen in this disease.

259 ss; secondary outcomes: changes in fat mass, muscle strength, sexual function, prostate volume, sebum

260 Changes in fat mass, muscle strength, sexual function, prostate volume, sebum

261 Examination of muscle strength showed reduced force generation in vivo

262 bone mineral content, cardiac function, and muscle strength significantly improved during rhGH treat

263 After initial improvement, muscle strength stabilizes or slowly declines, and skele

264 overy of alpha-DG glycosylation and improved muscle strength, suggesting a systemic supply of FKRP pr

265 ical therapist performed quantitative manual muscle strength testing (MMT) twice on each child (morni

266 history, assessed by bi-monthly Quantitative Muscle Strength Testing and Medical Research Council str

267 Muscle involvement was assessed by MRI, muscle strength testing and muscle biopsy analysis.

268 CU-acquired weakness was diagnosed by manual muscle strength testing as soon as patients were awake a

269 ned by a mean of 14.9% based on Quantitative Muscle Strength Testing.

270 We further conducted muscle strength tests in humans, chimpanzees, and macaqu

271 henotype, muscle physiology, and (except for muscle strength tests) motor behaviors were all normal a

272 s are much more susceptible to a decrease in muscle strength than the diaphragm, and impairment of up

273 ion, are the cause of the severe decrease in muscle strength that characterizes these patients.

274 Vitamin D may improve muscle strength through a highly specific nuclear recept

275 gregates, decreases muscle fibrosis, reverts muscle strength to the level of healthy muscles and norm

276 le ergometry can provide range of motion and muscle strength training for intensive care unit patient

277 e DM, and healthy children were assessed for muscle strength (using myometry) and function, and MRI T

278 In the critically ill, respiratory muscle strength usually has been assessed by measuring m

279 Changes in muscle strength, vastus lateralis fibre characteristics

280 Skeletal muscle strength, velocity, and power are markedly reduce

281 Celecoxib did not slow the decline in muscle strength, vital capacity, motor unit number estim

282 ts than the control condition in measures of muscle strength, walking speed, balance, and perceived h

283 Muscle strength was also unaffected by diabetes or glyce

284 Muscle strength was assessed at hospital discharge and a

285 Muscle strength was assessed by a hand grip test and the

286 Muscle strength was assessed during maximal voluntary is

287 the combination of low aerobic capacity and muscle strength was associated with a 3-fold risk for ty

288 An increase in muscle strength was detected in all treated animals and

289 Ankle dorsiflexor muscle strength was measured during maximal voluntary co

290 Muscle strength was measured with the British Medical Re

291 Loss of muscle strength was progressive in homozygous D187N gels

292 Improvement in muscle strength was significantly greater with resistanc

293 Respiratory muscle strength was tested by measuring maximal inspirat

294 opathological evaluation and measurements of muscle strength were accompanied by analyses of expressi

295 Low aerobic capacity and muscle strength were independently associated with incre

296 Changes in lean mass, muscle size, and muscle strength were similar between the groups.

297 r decline for direct measures of respiratory muscle strength, whereas VC showed little to no decline

298 e a number of ways for assessing objectively muscle strength, which can be categorized as techniques

299 ition with dual-energy X-ray absorptiometry, muscle strength with a handgrip dynamometer, and blood b

300 y comparing bilateral intrinsic hand and leg muscle strength with manual testing as well as manual de

301 y labeled water, exercise energy economy and muscle strength with the use of standardized exercise te